75410-1
Hepatitis B virus surface Ag [Presence] in Serum, Plasma or Blood by Rapid immunoassay
Active
Term Description
Hepatitis B surface antigen (HBsAg) rapid tests are available in test strip and cassette formats from manufacturers in various countries including the US, Singapore, and China. (As of 8/25/2014, no HBsAg rapid test kits are approved for use in the United States). Hepatitis B surface antigen (HBsAg) rapid tests are intended to be used for screening patients for hepatitis B infection and for screening blood donors and blood products. HBsAg is the first serologic marker to appear in the blood of patients infected with hepatitis B, prior to the onset of symptoms. HBsAg can be detected 2-4 weeks in advance of alanine aminotransferase (ALT) liver enzyme levels becoming increased, and 3-5 weeks prior to symptoms. This makes HBsAg rapid tests particularly useful for screening. Follow-up and supplementary testing of any positive samples with other analytical methods (e.g. ELISA, WB)are required however, and negative results do not exclude Hepatitis B virus (HBV) exposure or infection. This term was created for, but not limited in use to, the OneStep HBsAG RapiCard InstaTest kit which uses a chromatographic lateral flow device technique on whole blood, serum, or plasma. Test cassette must be at room temperature prior to testing and then results can be read within 15 minutes.
Source: Regenstrief LOINC
Part Description
LP14820-2 Hepatitis B virus surface
The hepatitis B surface antigen (HBsAg) is most frequently used to screen for the presence of this infection. It is the first detectable viral antigen to appear during infection. However, early in an infection, this antigen may not be present and it may be undetectable later in the infection as it is being cleared by the host. The infectious virion contains an inner "core particle" enclosing viral genome. The icosahedral core particle is made of 180 or 240 copies of core protein, alternatively known as hepatitis B core antigen, or HBcAg. During this 'window' in which the host remains infected but is successfully clearing the virus, IgM antibodies to the hepatitis B core antigen (anti-HBc IgM) may be the only serological evidence of disease. Therefore most hepatitis B diagnostic panels contain HBsAg and total anti-HBc(both IgM and IgG).
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Hepatitis B Virus
Fully-Specified Name
- Component
- Hepatitis B virus surface Ag
- Property
- PrThr
- Time
- Pt
- System
- Ser/Plas/Bld
- Scale
- Ord
- Method
- IA.rapid
Additional Names
- Short Name
- HBV surface Ag SerPlBld Ql IA.rapid
- Display Name
- HBV surface Ag IA.rapid Ql (S/P/Bld)
- Consumer Name Alpha Get Info
- Hepatitis B virus (HBV) Surface antigen, Blood
Example Answer List: LL2021-5
Source: Gen-ProbeAnswer | Code | Score | Answer ID |
---|---|---|---|
PositiveCopyright http://snomed.info/sct ID:10828004 Positive (qualifier value) | LA6576-8 | ||
NegativeCopyright http://snomed.info/sct ID:260385009 Negative (qualifier value) | LA6577-6 | ||
InvalidCopyright http://snomed.info/sct ID:455371000124106 Invalid result (qualifier value) | LA15841-2 |
Basic Attributes
- Class
- MICRO
- Type
- Laboratory
- First Released
- Version 2.50
- Last Updated
- Version 2.56
- Change Reason
- The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.
- Order vs. Observation
- Both
Member of these Groups Get Info
LOINC Group | Group Name |
---|---|
LG32752-4 | Hepatitis B virus |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-DE | German (Germany) | Hepatitis-B-Virus-surface Ag: Synonyms: Hepatitis-B-Virus-surface; |
es-ES | Spanish (Spain) | Antígeno de superficie virus Hepatitis B Antígeno: |
es-MX | Spanish (Mexico) | Ag de superficie del virus de la hepatitis B: |
et-EE | Estonian (Estonia) | B-hepatiidi viiruse pinnaantigeen antigeen: Synonyms: Järgarvuline Juhuslik Plasma Seerum Seerum või plasma Seerum või plasma või veri Veri |
fr-CA | French (Canada) | Surface du virus de l'hépatite B, Ag: |
fr-FR | French (France) | Hépatite B virus surface Ag: |
fr-BE | French (Belgium) | Antigène surface du virus de l'hépatite B Ag: Synonyms: Antigène Hbs, HbsAg HBV |
it-IT | Italian (Italy) | Epatite B virus, superficie, Ag: Synonyms: HBV Immunoassay Immunoassay rapido Microbiologia Plasma Plasma o Sangue Presenza o Soglia Punto nel tempo (episodio) Sangue Siero Siero o Plasma Siero,Plasma o Sangue Superficie del virus dell''epatite B |
nl-NL | Dutch (Netherlands) | Hepatitis B-virusoppervlakte Ag: Synonyms: antigeen IA IA.rapid |
pl-PL | Polish (Poland) | Powierzchnia wirusa zapalenia wątroby typu B Ag: Synonyms: Antygen powierzchniowy wirusa zapalenia wątroby typu B |
ru-RU | Russian (Russian Federation) | Гепатита В вируса поверхностный Аг: Synonyms: Кровь Плазма Порядковый Сыворотка Сыворотка или Плазма Сыворотка, Плазма или Кровь Точка во времени; |
tr-TR | Turkish (Turkey) | Hepatit B virüsü yüzey Ag: Synonyms: Antijen İmmünölçüm, immünoassay Mevcut |
zh-CN | Chinese (China) | 乙型肝炎病毒表面 抗原: Synonyms: Ag B 型 HBs Ag HBs 抗原 HBs; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=75410-1
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright